The Board of Directors of Terns Pharmaceuticals, Inc. (the "Company") has adopted the following policies and procedures to assist the Board in discharging its fiduciary duties and fulfilling its responsibilities, including providing effective oversight of the management of the Company and adhering to principles of sound corporate governance. These policies and procedures reflect the Board’s commitment to setting the highest standards of business conduct and ethics for the Company’s employees, officers and directors and to building long-term stockholder value with an emphasis on corporate governance. These policies and procedures are subject to modification from time to time as the Board of Directors deems appropriate in the best interests of the Company or as required by applicable laws and regulations.
Governance Documents
Committee Composition
| Director Name | Audit Committee | Compensation Committee | Nominating and Corporate Governance Committee | Research and Development Committee |
|---|---|---|---|---|
| David Fellows Chairman of the Board | Member of the Compensation CommitteeCompensation Committee | Chairperson of the Nominating and Corporate Governance CommitteeNominating and Corporate Governance Committee | ||
| Amy Burroughs | ||||
| Robert Azelby | Member of the Compensation CommitteeCompensation Committee | |||
| Jeffrey B. Kindler | Chairperson of the Compensation CommitteeCompensation Committee | |||
| Jill M. Quigley Financial Expert | Chairperson of the Audit CommitteeAudit Committee | Member of the Nominating and Corporate Governance CommitteeNominating and Corporate Governance Committee | ||
| Radhika Tripuraneni | Member of the Audit CommitteeAudit Committee | Chairperson of the Research and Development Committee Research and Development Committee | ||
| Heather Turner | Member of the Audit CommitteeAudit Committee |